Courtesy:
Professor Madhav Das Nalapat sits down with Manjeet Kripalani to discuss the ascendance of Xi Jinping into the pages of the Chinese Constitution and what this new status quo means for India and it's strategic interests.
Courtesy: Gateway House
The Indian government may block the acquisition of Gland Pharma by Shanghai Fosun Pharmaceuticals, a move that offers further confirmation of how China’s opaque business model is causing concern worldwide. This infographic shows some high-profile cases of acquisitions by Chinese companies that ran into local opposition
Courtesy: India Today
The origin of current India-China hostilities in Bhutan harks back to a colonial era agreement framed in 1890 between the British and the Qing empire on issues related to Tibet and Sikkim. The present standoff is an occasion to revisit many aspects of a relationship that has shown perennial strain